Bio Path Holdings Price on June 21, 2024
BPTHDelisted Stock | USD 0.19 0.01 5.00% |
If you're considering investing in Bio OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Bio Path stands at 0.19, as last reported on the 2nd of March, with the highest price reaching 0.22 and the lowest price hitting 0.16 during the day. Bio Path Holdings secures Sharpe Ratio (or Efficiency) of -0.0132, which signifies that the company had a -0.0132 % return per unit of risk over the last 3 months. Bio Path Holdings exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bio Path's Risk Adjusted Performance of (0.01), standard deviation of 20.29, and Mean Deviation of 8.68 to double-check the risk estimate we provide.
Bio OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Bio |
Sharpe Ratio = -0.0132
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BPTH |
Estimated Market Risk
21.96 actual daily | 96 96% of assets are less volatile |
Expected Return
-0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bio Path is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bio Path by adding Bio Path to a well-diversified portfolio.
Related Headline
Crinetics Pharmaceuticals Headline on 21st of June 2024
Disposition of 15000 shares by James Hassard of Crinetics Ph... by James Hassard
Filed transaction by Crinetics Pharmaceuticals Officer: Chief Commercial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Bio Path Valuation on June 21, 2024
It is possible to determine the worth of Bio Path on a given historical date. On June 21, 2024 Bio was worth 2.24 at the beginning of the trading date compared to the closed value of 2.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bio Path otc stock. Still, in general, we apply an absolute valuation method to find Bio Path's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bio Path where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bio Path's related companies.
Open | High | Low | Close | Volume | |
2.21 | 2.45 | 2.21 | 2.30 | 128,845 | |
06/21/2024 | 2.24 | 2.40 | 2.06 | 2.11 | 119,416 |
2.11 | 2.16 | 2.02 | 2.13 | 70,167 |
Backtest Bio Path | | | Bio Path History | | | Bio Path Valuation | Previous | Next |
Bio Path Trading Date Momentum on June 21, 2024
On June 24 2024 Bio Path Holdings was traded for 2.13 at the closing time. The top price for the day was 2.16 and the lowest listed price was 2.02 . The trading volume for the day was 70.2 K. The trading history from June 24, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 0.95% . The overall trading delta against the current closing price is 4.27% . |
Bio Path Holdings Fundamentals Correlations and Trends
By evaluating Bio Path's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bio Path's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bio Path OTC Stock history
Bio Path investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bio Path Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bio Path stock prices may prove useful in developing a viable investing in Bio Path
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas. Bio-Path Holdings operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Bio Path OTC Stock Technical Analysis
Bio Path technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Bio Path Period Price Range
Low | March 2, 2025
| High |
0.00 | 0.00 |
Bio Path Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQX Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bio Path March 2, 2025 Market Strength
Market strength indicators help investors to evaluate how Bio Path otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Path shares will generate the highest return on investment. By undertsting and applying Bio Path otc stock market strength indicators, traders can identify Bio Path Holdings entry and exit signals to maximize returns
Bio Path Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bio Path's price direction in advance. Along with the technical and fundamental analysis of Bio OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.01) | |||
Jensen Alpha | (0.62) | |||
Total Risk Alpha | 0.1009 | |||
Treynor Ratio | 0.1481 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Path Holdings. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Bio OTC Stock
If you are still planning to invest in Bio Path Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bio Path's history and understand the potential risks before investing.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |